Sanofi India Limited (SANOFI.BO)

INR 6090.0

(-0.54%)

Market Cap (In INR)

140.25 Billion

Revenue (In INR)

28.51 Billion

Net Income (In INR)

6.02 Billion

Avg. Volume

1386.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5850.55-10526.05
PE
-
EPS
-
Beta Value
0.279
ISIN
INE058A01010
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Rodolfo Hrosz
Employee Count
-
Website
https://www.sanofiindialtd.com
Ipo Date
2000-01-03
Details
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, antihistamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.